Pfizer to sell infant nutrition unit

NEW YORK — Pfizer Inc. has decided to sell its infant nutrition business as soon as next week, The New York Times reported.

According to the story, Nestle appears to be the leading bidder for the business.

The unit, which reported about $2.1 billion in revenue last year, manufactures infant formula products around the world and is considered to be among Pfizer’s faster-growing businesses.